← FDA Drug Approvals (Drugs@FDA)
METHYLPHENIDATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN TECH VIATRIS · Approved 2022-03-14
Drug application
- FDA Application #
ANDA206497- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- METHYLPHENIDATE
- Generic name
- METHYLPHENIDATE
- Active ingredients
- METHYLPHENIDATE
- Dosage form
- FILM, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing status
- Prescription
- Sponsor
- MYLAN TECH VIATRIS
- Manufacturer
- Mylan Pharmaceuticals Inc.
- First approval
- 2022-03-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown